Natco Pharma Ltd. | Cash Flow

Fiscal year is April-March. All values INR Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
1,290
1,342
2,015
6,244
8,872
-
Depreciation, Depletion & Amortization
304
473
510
544
662
-
Other Funds
10
75
-
-
-
-
Funds from Operations
1,264
1,491
2,284
5,905
7,527
-
Changes in Working Capital
161
860
1,407
2,528
2,946
-
Net Operating Cash Flow
1,103
631
877
3,377
4,581
-
Capital Expenditures
1,104
1,192
1,574
2,795
4,243
Sale of Fixed Assets & Businesses
-
17
23
3
185
Purchase/Sale of Investments
15
26
391
279
7,191
Net Investing Cash Flow
1,095
1,151
1,770
3,065
11,249
Cash Dividends Paid - Total
193
199
261
1,409
1,814
Issuance/Reduction of Debt, Net
911
714
1,291
142
484
Net Financing Cash Flow
10
590
1,792
1,551
6,658
Net Change in Cash
3
22
899
1,239
18
Free Cash Flow
43
536
697
585
356
Other Sources
-
-
180
6
-
Change in Capital Stock
1,085
-
3,344
-
8,956
Exchange Rate Effect
4
48
-
-
8
Other Uses
6
2
8
-
-

About Natco Pharma

View Profile
Address
NATCO House
Hyderabad TS 500034
India
Employees -
Website http://www.natcopharma.co.in
Updated 07/08/2019
NATCO Pharma Ltd. engages in the business of pharmaceuticals which comprises research and development, manufacturing and selling of bulk drugs and finished dosage formulations. It operates through the following segments: Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients. The Domestic Formulations is a leading player in India's oncology segment with 28 active brands.